
Core Viewpoint - Optinose is set to report its financial results for the second quarter of 2024 and provide corporate updates on August 8, 2024, before market open [1] Group 1: Financial Results Announcement - The company will announce its second quarter 2024 financial results and corporate updates [1] - The announcement is scheduled for Thursday, August 8, 2024, before the market opens [1] Group 2: Conference Call Details - A conference call will be hosted by the company's leadership team to discuss the financial results and corporate updates [2] - The call is scheduled to start at 8:00 a.m. Eastern Time on August 8, 2024 [2] Group 3: Participation Information - Participants can access the conference call live via webcast on the Investors section of Optinose's website [3] - Telephone participants must register in advance to receive a confirmation email with dial-in details and a personal PIN [3] - A replay of the webcast will be available on the company website for 60 days following the event [3] Group 4: Company Overview - Optinose is a specialty pharmaceutical company focused on patients treated by ear, nose, and throat (ENT) and allergy specialists [4] - Additional information about the company can be found on its website and social media platforms [4]